FindTrial
Sign In

Oral administration

DRUG12 trials

Sponsors

The First Affiliated Hospital,Sun Yat-sen University, Basilea Pharmaceutica International AG Allschwil, Yamamoto Noboru, Nagao Kiminori, Namiki Takao

Conditions

AnesthesiaCOVID-19 Respiratory Tract InfectionsCandidemiaChronic EndometritisExerciseHealthy AdultsHealthy subjectsInvasive candidiasis

Early Phase 1

Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions
Active, not recruitingNCT06716047
Zhujiang HospitalMicroecological Therapy, Probiotic Intervention
Start: 2024-12-05End: 2025-12-30Updated: 2026-01-07

Phase 1

Phase 1 study of DS-3201b to evaluate the effect of food (low-fat meal) on the pharmacokinetics in healthy subjects
Active, not recruitingJPRN-jRCT2071200043
Nagao KiminoriHealthy subjects
Start: 2020-10-31Target: 28Updated: 2025-07-18
NCCH2303 trial
RecruitingJPRN-jRCT2031240210
Yamamoto NoboruPatients with Unresectable advanced or recurrent solid tumors Solid tumor
Start: 2024-07-24Target: 42Updated: 2025-07-18

Phase 2

Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic Endometritis
NCT05205993
Genesis Athens ClinicChronic Endometritis
Start: 2021-01-19End: 2024-04-30Target: 90Updated: 2023-02-24
Effect of tranilast on facial neuralgia
RecruitingJPRN-jRCTs061230013
Ikutame DaisukeTrigeminal neuralgia Trigeminal neuropathic pain
Start: 2023-10-25Target: 15Updated: 2025-07-18
Effect of Kampo medicine on those who plan to receive the new COVID-19 vaccine
RecruitingJPRN-jRCTs031230190
Namiki TakaoThose who are scheduled to receive the new corona vaccine new corona vaccination
Start: 2023-06-28Target: 40Updated: 2025-07-18

Phase 3

Prophylactic study for COVID-19 with Kampo medicines
RecruitingJPRN-jRCTs031200150
Namiki TakaoCOVID-19 Respiratory Tract Infections
Start: 2020-11-27Target: 6000Updated: 2025-07-18
An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepix compared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis.
RecruitingCTIS2022-500455-23-00
Basilea Pharmaceutica International AG AllschwilCandidemia, Invasive candidiasis
Start: 2024-12-11Target: 157Updated: 2025-11-12

Phase 4

The Comparison of Different Administration Routes of Pediatric Premedication
NCT02313337
Second Affiliated Hospital of Xi'an Jiaotong UniversityAnesthesia
Start: 2014-12-31End: 2015-12-31Target: 80Updated: 2014-12-10
The efficacy of elobixibat as bowel cleansing agent for bowel preparation before colonoscopy
Active, not recruitingJPRN-jRCTs041180026
Yamaguchi Daisukerequire colonoscopy colonoscopy
Start: 2018-01-07Target: 154Updated: 2025-07-18

Unknown Phase

Acute Effect of Polyphenols Supplementation on Endothelial Function and Exercise Related Markers, in Physically Active Healthy Volunteers.
Active, not recruitingNCT07518758
NexiraExercise, Healthy Adults, Vasodilation
Start: 2025-09-01End: 2026-04-27Target: 38Updated: 2026-04-13
Protocol for a Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study on the Safety and Efficacy of Brivaracetam in Preventing Post-Stroke Epilepsy Associated with Thrombolysis
RecruitingChiCTR2600123322
The First Affiliated Hospital,Sun Yat-sen UniversityStroke is the most serious disease endangering human health. Stroke is one of the most common causes of epilepsy in adulthood. The incidence of post-stroke epilepsy (PSE) is 3.1%-28.7%. Based on the time of onset after stroke, it can be divided into early PSE (onset 7 days after stroke).
Start: 2025-11-25Updated: 2026-05-04

Related Papers

A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
2021-01-068 citations